Genmab

Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

Latest News

Subscribe to Genmab News

Genmab has implemented a new email alert system to serve you better.  Previous subscribers who wish to continue receiving news alerts via email, must re-subscribe with our new system.  To re-subscribe or newly subscribe, click here and fill out the form.

 

Upcoming Events and Presentations

Check out the events that Genmab will present at both in Denmark and internationally. For more information, click here.

1

Genmab’s state-of-the-art manufacturing facility is for sale

The facility, located on 36 acres in Brooklyn Park, Minnesota includes both manufacturing and development facilities with opportunities for expansion. Visit http://genmab-facility.com to learn more.